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ABSTRACT - The authors present a cross-sectional study involving 61 patients with idiopathic Parkinsons
disease (PD) who were consecutively examined and compared to a control group with 74 subjects. Only
patients who fulfilled the standard diagnostic criteria for PD and whose brain magnetic resonance imaging
was normal were included. The objective of the study was to evaluate the prevalence of inferior urinary tract
symptoms in PD and to study the possible association between clinical factors to urinary dysfunction. ln the
patient group, 39.3% presented urinary symptoms when compared to 10.8% in the control group. All
symptomatic patients presented irritative symptoms. The most common irritative symptom PD was nocturia,
followed by frequency and urinary incontinence. Around 25% of the patients presented functional obstructive
symptoms determined by the disease. The most frequent obstructive symptom was incomplete emptying of
the bladder. Only the age of the patients and control group were correlated with urinary dysfunction.
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Prevalência e fatores associados aos sintomas urinários na doença de Parkinson
RESUMO - Trata-se de estudo clínico transversal, envolvendo 61 pacientes com doença de Parkinson idiopática
(DP) examinados consecutivamente e comparados a 74 indivíduos do grupo controle. Foram incluídos apenas
pacientes com DP que preencheram os critérios de diagnóstico estabelecidos. A ressonância magnética do
encéfalo e a ultra-sonografia da próstata foram utilizadas como critérios de exclusão. O objetivo do estudo foi
avaliar a prevalência de sintomas do trato urinário inferior na DP e verificar associações entre sexo, idade e
fatores clínicos às disfunções urinárias. Sintomatologia urinária foi encontrada em 39,3% dos parkinsonianos
e 10,8% do grupo controle. Todos os pacientes sintomáticos apresentavam sintomas irritativos e 25% destes
tinham sintomas obstrutivos. A sintomatologia urinária não estava associada ao sexo, duração e gravidade da
doença, hipotensão postural e sintomas ortostáticos, assim como com os sinais cardeais e tratamento com a
levodopa.
PALAVRAS-CHAVE: doença de Parkinson, sintomas urinários, sintomas autonômicos.
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The presence of autonomic alterations in Parkin-
sons Disease (PD) could influence the diagnosis and
prognosis of the disease. In 1817, James Parkinson
reported the presence of autonomic signs such as
sudoresis, urinary and gastrointestinal symptoms1.
The lower urinary tract symptoms (LUTS) are classified
in irritative and obstructive symptoms. In the irritative
group, there are frequency, urgency and nocturia
which are caused by hyperactivity of the bladder due
to detrusor hyperreflexia. Incomplete emptying,
intermittence, weak urinary stream and hesitation
are obstructive symptoms. The majority of LUTS
found in PD are irritative. Obstructive symptoms or
both irritative and obstructive are less frequently
found2,3. Detrusor hyperreflexia means a hyperactive
bladder due to central nervous system mechanisms.
Neurological disorders frequently associated with de-
trusor hyperreflexia are cerebrovascular disorders,
dementia, multiple sclerosis, brain tumor and par-
kinsonism4 . According to epidemiological studies of
urinary disorders related by Martins Jr. and DAncona
9% of the patients with urinary incontinence had
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PD5.The frequency of urinary symptoms in patients
with PD revised by Araki and Kuno varied from 37 to
70%3. The distortions in these studies include pro-
blems in selecting patients, inclusion of patients with
other forms of parkinsonism, the identification of
urinary symptoms and the use of medication such
as levodopa3,6. Bladder hyperactivity in PD patients
can be explained by the removal of inhibitory effects
exerted by dopamine neurons, originated in the pars
compacta of the substantia nigra and mediated by
D1 receptors, on the urinary reflex6,7. The presence
of Lewy bodies in the autonomic nervous system of
patients with advanced PD can explain urinary
sphincter dysfunction and rare cases of hyporeflexia
of the detrusor muscle3.
LUTS can be measured by using the score scale of
the American Urological Association (AUA  7). This
scale is a questionnaire of 7 items which was developed
to measure the severity of LUTS among men who have
prostate hypertrophy8. It quantifies the urinary
symptoms and has correlation with urodynamic
findings even in patients without prostate alteration
or in females. It can also measure and differentiate
the irritative and obstructive symptoms8,9. Patients who
have total scores ≥ 8 or irritative scores ≥ 4 and
obstructive scores ≥ 5 are considered symptomatic8.
The objective of this study was to analyze the
prevalence of LUTS in PD and to study the possible
association of sex, age and clinical factors to urinary
disorders.
METHOD
The study was comprised of 61 patients selected from
169 patients with PD who were attended consecutively at
the neurological outpatient clinic of Lineu Araujo  SUS
Teresina  PI. The control group (74 subjects) was made
up of spouses, family and caretakers. Only patients with
idiopathic PD who fulfilled the criteria for the established
diagnosis were included. Secondary parkinsonism and
other types of degenerative parkinsonism were excluded.
A brain MRI was done on all participants as exclusion cri-
teria. Patients with dementia, early or severe postural insta-
bility, men with prostate hypertrophy or previous prosta-
tectomy and pelvic surgery in women were also excluded.
All of the patients were examined after being off levodopa
or other dopaminergic medication for 15 hours.
The Unified Parkinsons Disease Rating Scale (UPDRS)
and the Hoehn-Yahr scale were used for neurological eva-
luation. The urinary symptoms were evaluated by AUA-7
scale, which was applied with assistance of the same exa-
miner (RNCS).
An analytic and observational cross-sectional study was
conducted. For descriptive analysis, frequency tables,
position and dispersion measurements were used. For the
study of association between the variables, the Pearson
correlation test was used. The statistic T of Student and
the variance analysis (ANOVA) were used to compare the
mean scores between the groups. The exact Fisher test
was used to study the proportions. The significance level
used was 5%.
RESULTS
Sex difference and age - In the patient group 31
(50.8%) were male and 30 (49.2%) female, in the
control group 31 (41.9%) were male and 43 (58.1%)
female. A significant difference between total
(p=0.529) irritative (p=0.94) and obstructive
(p=0.053) mean urinary scores for men and women
with PD was not observed (Table 1). In Table 2, the
mean urinary scores were compared between wo-
men with PD and women in the control group and a
significant difference between total (p<0.001), obs-
tructive and irritative mean urinary scores was ob-
served. The average age of the group of patients
(PD) was 59.6 years. For men, the ages varied from
36 to 77 years with the mean age of 57 and for
women the ages varied from 40 to 82 years with
mean age of 62 years. In the symptomatic group
the ages varied from 40 to 77 years, with mean age
of 62.2 years. In the control group the average of
age was 59.3 years.
In the PD group a correlation between age and
total urinary scores (r=0.351; p=0.0027) and
between age and irritative urinary scores (r=0.348;
p = 0.0029) was observed. There was no correlation
between age and obstructive symptoms (r= 0.197;
p= 0.0635). For the control group there was a clear
correlation between age and total urinary scores (r=
0.46; p<0.001).
Table 1. Mean urinary scores (AUA-7) between the groups.
Groups N AUA - 7
Total Irritative Obstructive
PD 61 7.1 5.2 1.9
Control 74 3.8 2.7 1.1
Table 2. Mean urinary scores (AUA-7) between women groups.
Women N AUA - 7
Groups Total Irritative Obstructive
Control 43 3.1 2.5 0.6
      PD 30 6.7 5.2 1.5
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Comparing groups - There was a significant diffe-
rence between total (p<0.0001) irritative (p<0.0001)
and obstructive (p<0.0001) mean urinary scores of
PD patients and control group. In the group of pa-
tients studied, we found 24 patients with total uri-
nary scores ≥ 8, corresponding to 39.3% of the to-
tal. All of the symptomatic patients had irritative
symptoms and 25% of them also had obstructive
symptoms.
In Table 3 there were significant differences bet-
ween nocturia (p<0.001), diurnal frequency
(p<0.001), urgency (p<0.001), and incomplete voi-
ding (p<0.001), when the patients group was com-
pared to the control group.
Duration and severity - The duration of PD varied
from 3 months to 20 years, with mean of 4.9 years
and median of 3 years. In the symptomatic patients,
the duration of disease varied from 1 to 11 years
with mean of 4.5 years. No association between the
duration of the disease and total (r=-0.004; p=0.48),
irritative and obstructive urinary scores was observed.
The severity of PD in the sample studied was mea-
sured by using the UPDRS scores. The UPDRS total
scores varied from 12 to 98 with mean of 45.8, me-
dian of 41 and standard deviation of 22. Among the
group of symptomatic patients, the mean total sco-
res was 51.6 while in the non-symptomatic group
the mean was 42. No significant difference between
the mean total scores (p=0.097) of symptomatic and
non-symptomatic PD patients was observed. In Table
4, the mean scores of the cardinal motor symptoms
(UPDRS) were distributed between patients with and
without urinary symptoms. No difference was obser-
ved in the mean motor scores of tremor (p=0,255),
rigidity (p=0,255) and akinesia (p=0,229) between
patients with or without symptoms. In Table 5, the
mean scores of each section (UPDRS) of PD patients
with and without urinary symptoms were compared
and no significant difference between the mean
scores for sector I-mental health, behavior and hu-
mor (p=0.73), sector II-daily activities (p=0.86) and
sector III- motor functions (p=0.119) was observed.
No correlation between the total points of the UPDRS
and the total urinary scores (r=0.14; p=0.136) was
observed. The possible associations of each cardinal
motor symptom with total urinary scores were also
studied: tremor (r=0.062; p=0.315); rigidity
(r=0.044; p=0.367) and akinesia (r=0.069;
p=0.296). No correlation between the motor cardi-
nal symptoms and urinary symptoms was found.
Orthostatic symptoms and postural hypotension
- Significant difference between the mean total uri-
nary scores of PD patients with or without orthostatic
symptoms (p=0.948) and with or without postural
hypotension (p=0.76) was not observed.
Table 5. Distribution of mean UPDRS scores between symptomatic
and non-symptomatic patients.
PD patients                                     UPDRS
Sector I Sector II Sector III
Symptomatic 1.83 12.62 37.2
Non-symptomatic 1.73 9.27 31.08




Symptomatic 6.67 6.45 18.80
Non- symptomatic 5.56 5.51 16.30
 Table 3. Prevalence of urinary symptoms between the groups.
        LUTS PD Controls  
N % N % P
Nocturia 39 63.9 21 32.8 < 0.001
Frequency 22 36.1 7 10.9 < 0.001
Urgency 20 32.8 6 9.4 < 0.001
Incomplete emptying 11 18.0 0 0 < 0.001
Intermittence 8 13.1 3 4.69 NS
Weak urinary stream 6 9.8 10 15.6 NS
Hesitation 1 1.6 1 1.56 NS
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Arterial hypertension - Total (p=0.080), irritative
(p=0.084) and obstructive (p=0.352) urinary scores
between hypertensive and normotensive PD patients
were compared and no difference was observed.
Levodopa - There was no significant difference
among total (p=0.831), irritative (p=0.473) and
obstructive (p=0.377) mean urinary scores of
patients who were treated with levodopa and those
treated without levodopa.
DISCUSSION
The identification, in the initial phase of parkin-
sonism, of autonomic symptoms such as urinary
symptoms could influence the diagnosis, treatment
efficacy and life quality. However, there have been
few studies done on the prevalence of LUTS in pa-
tients included with established criteria for PD diag-
nosis from neurological clinics. The majority of the
urological studies on PD evaluated patients that had
been sent to urological outpatient clinics with LUTS,
which biased the selection. The treatment of urinary
symptoms in PD patients is sometimes unsuccessful
because LUTS could have neurological origin or be a
result of drugs such as levodopa or dopaminergic
agents and, particularly in men, it could be associated
with structural factors like prostate hypertrophy3,10,11.
When we compared the mean urinary scores bet-
ween the PD patients and control group the preva-
lence of urinary dysfunction determined by PD was
significant. In this study, the symptomatic patient
was 39.3% against 10.8% of non-symptomatic pa-
tients. All the symptomatic patient had irritative
symptoms and 25% of them also had obstructive
symptoms. The prevalence of symptomatic patients
in past studies varied from 27% to 75%3,10,12. This
variation probably occurs due to the bias selection
in urological clinics11,13 or inclusion of other kinds of
parkinsonism3. Lemack et al. related that patients
with PD would have more contact with physicians,
which could influence the questionnaire answers10.
As the control group was made up of spouses, family
and caretakers they had the same health information
and the same access to health care.
The PD group urinary scores were compared by
gender and no significant difference between total
and irritative AUA-7 scores was noted. This suggests
that LUTS were not related to sex, which is in agree-
ment to previous studies3,10. There was no significant
difference between mean obstructive scores for both
women and men in the same groups. The prevalence
of obstructive symptoms in men caused by prostate
and urethral disease could difficult the evaluation
of the results in PD patients5. Probably this was not
observed in the groups studied because men with
prostate hypertrophy and previous prostatectomy
were excluded. To avoid this kind of distortion wo-
men, both from PD and control group, were com-
pared and there was significant difference. This rein-
forces the evidence that urinary dysfunction either
irritative or obstructive are related to the disease12.
Obstructive urinary symptoms could be explained by
sphincter and/or somatic pelvic muscle dysfunction.
Galloway reported that the bradykinetic external
sphincter was responsible for the obstructive symp-
toms14. More recently this opinion was questioned
by Myers et al.15. In the PD group a correlation bet-
ween age and total and irritative scores was obser-
ved. In the control group, total, irritative and obs-
tructive urinary scores were strongly associated with
age. In cross-sectional studies such as this, we can
only infer that urinary dysfunction is age-associated
and not an age effect13 .
In the sample studied the duration of PD was not
correlated with its severity, specifically motor symp-
toms severity. There was no association between du-
ration and urinary symptoms. These facts could be
explained by different ages at the onset of the disease
according to Diamond et al.16. By using UPDRS, it
was possible to quantify severity and clinical aspects
of the disease such as mental state, daily life activity
and motor function. Only daily life activity was
weakly associated with total urinary symptoms. No
difference was observed in the mean total scores of
the UPDRS, between symptomatic and non-symp-
tomatic patients suggesting that urinary symptoms
were not correlated with severity of the disease. Araki
et al. whose studies were based on the Hoenh-Yahr
scale and urodynamic methods concluded that
urinary function could become progressively worse
with PD deterioration3.
The possible correlation between the presence
of autonomic symptoms and LUTS in the patients
with PD was studied. The variables studied were the
presence of symptoms when in orthostatic position
such as: dizziness, blurred vision, syncope and pos-
tural hypotension. The presence of these autonomic
symptoms studied separately in PD patients was not
correlated to urinary symptoms. The urinary scores
of hypertensive and normotensive PD patients were
compared, and no significant difference was observed,
which agrees with the study of Koskimaki et al.17.
Differences in the urinary symptomatology bet-
ween those who used and those who did not use
levodopa were not found. The simultaneous use of
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two or more drugs such as levodopa, anticholinergic
agents and dopaminergic agonistics, could potenti-
ally cause LUTS, which limits the possibility of
studying the role of each one separately3,11.
CONCLUSION
Lower urinary tract symptoms were prevalent in
39% of the patients in our study. All the symptomatic
patients presented irritative symptoms and 25% also
presented functional obstructive symptoms. The
most frequent irritative symptoms were nocturia
followed by frequency and urinary urgency. The most
frequent obstructive symptom was incomplete
emptying. Sex, duration and severity of the disease,
autonomic symptoms represented by postural
hypotension and orthosthatic symptoms, the cardi-
nal symptoms (tremor, bradykinesia and rigidity) and
levodopa treatment were not associated with urinary
symptoms.
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